Distribution Characteristics and Prognostic Value of Immune Infiltration in Oligometastatic Breast Cancer

被引:3
作者
Zhou, Danyang [1 ]
Jiang, Kuikui [1 ]
Hong, Ruoxi [1 ]
Lu, Qianyi [1 ]
Xia, Wen [1 ]
Li, Mei [2 ]
Zheng, Chengyou [2 ]
Zheng, Qiufan [1 ]
Xu, Fei [1 ]
Wang, Shusen [1 ]
机构
[1] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Dept Med Oncol,Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Dept Pathol,Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
基金
中国国家自然科学基金;
关键词
immune infiltration; primary tumor; oligometastatic lesion; intratumoral; peritumoral; prognostic value; oligometastatic breast cancer; COLORECTAL-CANCER; T-CELLS; SURVEILLANCE; LYMPHOCYTES; MECHANISMS; LANDSCAPE; DISEASE;
D O I
10.3389/fonc.2021.747012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundTo assess the distribution characteristics and the prognostic value of immune infiltration in female oligometastatic breast cancer patients. MethodsWe retrospectively analyzed the clinicopathological data of oligometastatic breast cancer (OMBC) patients diagnosed between June 2000 and January 2020. Immune markers were quantified by immunohistochemistry on FFPE tissues in paired normal breast tissues, primary breast cancers and oligometastatic lesions. Survival analyses were performed using the Kaplan-Meier curves and Cox-proportional hazards model. ResultsA total of 95 female OMBC patients visited Sun Yat-sen University Cancer Center between June 2000 and January 2020, and 33 of them had matched normal breast tissues, primary cancers and oligometastatic lesions and were reviewed in immune infiltration analysis. CD8 of primary tumors had a higher expression than that in matched normal tissues. The expressions of CD8 and FOXP3 were higher in the primary sites than that in the oligometastatic lesions. CD3, CD4 and CD8 were significantly lower in the intratumoral regions than that in the peritumoral regions both in primary and oligometastatic lesions. Notably, the high percentage of CD3 in the intratumoral oligometastatic lesions predicted the longer PFS and OS, and higher CD4 in the same lesions also predicted a better OS. There was obviously positive correlation between CD4/CD3 and Ki-67 in primary cancers and negative correlation between CD4/CD3 and ER in oligometastatic sites. ConclusionWe explored immune distribution and evolution in time and space in OMBC to provide new understandings for biological behaviors of this disease and further divided patients in different prognosis.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Immune Cell Infiltration in the Microenvironment of Liver Oligometastasis from Colorectal Cancer: Intratumoural CD8/CD3 Ratio Is a Valuable Prognostic Index for Patients Undergoing Liver Metastasectomy
    Peng, Jianhong
    Wang, Yongchun
    Zhang, Rongxin
    Deng, Yuxiang
    Xiao, Binyi
    Ou, Qingjian
    Sui, Qiaoqi
    Xu, Jing
    Qin, Jiayi
    Lin, Junzhong
    Pan, Zhizhong
    [J]. CANCERS, 2019, 11 (12)
  • [32] PENN I, 1988, ANNU REV MED, V39, P63, DOI 10.1146/annurev.me.39.020188.000431
  • [33] New Strategies in Breast Cancer: Immunotherapy
    Pusztai, Lajos
    Karn, Thomas
    Safonov, Anton
    Abu-Khalaf, Maysa M.
    Bianchini, Giampaolo
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (09) : 2105 - 2110
  • [34] The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
    Salgado, R.
    Denkert, C.
    Demaria, S.
    Sirtaine, N.
    Klauschen, F.
    Pruneri, G.
    Wienert, S.
    Van den Eynden, G.
    Baehner, F. L.
    Penault-Llorca, F.
    Perez, E. A.
    Thompson, E. A.
    Symmans, W. F.
    Richardson, A. L.
    Brock, J.
    Criscitiello, C.
    Bailey, H.
    Ignatiadis, M.
    Floris, G.
    Sparano, J.
    Kos, Z.
    Nielsen, T.
    Rimm, D. L.
    Allison, K. H.
    Reis-Filho, J. S.
    Loibl, S.
    Sotiriou, C.
    Viale, G.
    Badve, S.
    Adams, S.
    Willard-Gallo, K.
    Loi, S.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 (02) : 259 - 271
  • [35] Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
    Savas, Peter
    Virassamy, Balaji
    Ye, Chengzhong
    Salim, Agus
    Mintoff, Christopher P.
    Caramia, Franco
    Salgado, Roberto
    Byrne, David J.
    Teo, Zhi L.
    Dushyanthen, Sathana
    Byrne, Ann
    Wein, Lironne
    Luen, Stephen J.
    Poliness, Catherine
    Nightingale, Sophie S.
    Skandarajah, Anita S.
    Gyorki, David E.
    Thornton, Chantel M.
    Beavis, Paul A.
    Fox, Stephen B.
    Cuningham, Kathleen
    Darcy, Phillip K.
    Speed, Terence P.
    Mackay, Laura K.
    Neeson, Paul J.
    Loi, Sherene
    [J]. NATURE MEDICINE, 2018, 24 (07) : 986 - 993
  • [36] Clinical relevance of host immunity in breast cancer: from TILs to the clinic
    Savas, Peter
    Salgado, Roberto
    Denkert, Carsten
    Sotiriou, Christos
    Darcy, Phillip K.
    Smyth, Mark J.
    Loi, Sherene
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (04) : 228 - 241
  • [37] Epitope landscape in breast and colorectal cancer
    Segal, Neil H.
    Parsons, D. Williams
    Peggs, Karl S.
    Velcutlescu, Victor
    Kinzler, Ken W.
    Vogelstein, Bert
    Allison, James P.
    [J]. CANCER RESEARCH, 2008, 68 (03) : 889 - 892
  • [38] Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
    Sung, Hyuna
    Ferlay, Jacques
    Siegel, Rebecca L.
    Laversanne, Mathieu
    Soerjomataram, Isabelle
    Jemal, Ahmedin
    Bray, Freddie
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2021, 71 (03) : 209 - 249
  • [39] Immune surveillance of tumors
    Swann, Jeremy B.
    Smyth, Mark J.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (05) : 1137 - 1146
  • [40] Immunological differences between primary and metastatic breast cancer
    Szekely, B.
    Bossuyt, V.
    Li, X.
    Wali, V. B.
    Patwardhan, G. A.
    Frederick, C.
    Silber, A.
    Park, T.
    Harigopal, M.
    Pelekanou, V.
    Zhang, M.
    Yan, Q.
    Rimm, D. L.
    Bianchini, G.
    Hatzis, C.
    Pusztai, L.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (11) : 2232 - 2239